Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Early Detection of COPD to Prevent Cardiovascular Deterioration via Multimodal Digital Monitoring (C-COPE)

Reference number
Coordinator GattyInstruments AB
Funding from Vinnova SEK 494 594
Project duration December 2025 - May 2026
Status Completed
Venture Global cooperation 2025
Call Planning grant for international proposal 2025

Important results from the project

The project goals were largely achieved through successful grant preparation, partner discussions, and consolidation of the project structure and objectives for the main application. The project improved understanding of clinical study requirements and budget prioritization, reducing uncertainties for future implementation. In addition, collaborations and networks within healthcare and industry were strengthened, while new opportunities for product applications and partnerships were identified.

Expected long term effects

Long-term, C-COPE shifts COPD-CVD management from reactive to proactive outpatient monitoring. Early detection prevents severe cardiovascular deterioration, reducing hospitalizations and increasing healthy life years. It delivers substantial healthcare savings and provides a scalable digital health model for other chronic diseases.

Approach and implementation

Led by GattyInstruments, C-COPE was structured across five interdisciplinary work packages spanning Sweden, France, and Türkiye. The implementation integrated mature technologies like Spiroluft and BORA Care into a secure federated platform. Rather than basic research, the project focused on co-designing and validating a real-world, nurse-led "alert-to-action" clinical pilot for 120 patients.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 6 June 2026

Reference number 2025-04488